Web Stats Provided By Google Analytics

Wednesday, April 17, 2013

Phase II Trial Targeting ALS Treatment Receives FDA Approval

According to a recent news release, the US Food and Drug Administration has approved a Phase II clinical trial of stem cell injections in patients with amyotrophic lateral sclerosis .

http://www.rehabpub.com/news2/18789-phase-ii-trial-targeting-als-treatment-receives-fda-approval

No comments:

Post a Comment

Popular Healthcare Law Roundup Posts